San Francisco Sentry Investment Group’s Adaptive Biotechnologies ADPT Stock Holding History

San Francisco Sentry Investment Group’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$25K	Sell	622 -8	-1%	-$311	0.01%	451
2021 Q1	$25K	Sell	630 -50	-7%	-$2.71K	0.01%	461
2020 Q4	$40K	Sell	680 -2	-0.3%	-$103	0.02%	380
2020 Q3	$33K	Sell	682 -10	-1%	-$420	0.02%	376
2020 Q2	$33K	Buy	692 +413	+148%	+$15.1K	0.02%	374
2020 Q1	$8K	Hold	279	–	–	0.01%	499
2019 Q4	$8K	Hold	279	–	–	﹤0.01%	582
2019 Q3	$9K	Buy	+279	New	+$11.4K	﹤0.01%	560

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

San Francisco Sentry Investment Group's ADPT Position: Q2 2021 in Review

San Francisco Sentry Investment Group reduced its Adaptive Biotechnologies (ADPT) stake by 1.3% in Q2 2021, selling an estimated $311 and leaving 622 shares worth $25K. The position accounts for 0.01% of the portfolio, ranked #451.

San Francisco Sentry Investment Group first reported a position in ADPT in Q3 2019 and has held it in 8 quarters since. The position peaked at $40K in Q4 2020. 230 funds tracked by Wall St. Rank hold ADPT as of Q2 2021.

San Francisco Sentry Investment Group held 622 shares of Adaptive Biotechnologies worth $25K as of Q2 2021.
San Francisco Sentry Investment Group sold 8 Adaptive Biotechnologies shares in Q2 2021, an estimated $311.
Adaptive Biotechnologies made up 0.01% of San Francisco Sentry Investment Group's portfolio in Q2 2021, its #451 holding.
San Francisco Sentry Investment Group first reported a position in Adaptive Biotechnologies in Q3 2019 and has held it in 8 quarters since.
San Francisco Sentry Investment Group's Adaptive Biotechnologies position peaked at $40K in Q4 2020.
230 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2021.

Based on San Francisco Sentry Investment Group's 13F filing for Q2 2021, filed 2 Aug 2021.